DDP Therapeutics
2005
FOUNDED
M&A
STATUS
M&A
LATEST DEAL TYPE
2
FINANCING ROUNDS
Description
Manufacturer of drugs. The company develops early stage compounds used in the treatment of small cell lung cancer ("SCLC").
Website
Formerly Known As
6441513 Canada
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- 1547 Merivale Road
- P.O. Box 5087
- Ottawa, Ontario K2C 3H3
- Canada
DDP Therapeutics Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore DDP Therapeutics‘s full profile, request access.
Request full access to PitchBookDDP Therapeutics Executive Team (2)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| J.L. Scott Baker | Chief Executive Officer & President |
1 Former Executive
You’re viewing 1 of 2 executives. Get the full list »